Revecore Launches AI-Powered Underpayment Recovery and Denial Appeals Capabilities
New capabilities accelerate underpayment recovery and denial appeals resolution - helping health systems recover more earned revenue as reimbursement complexity...
New capabilities accelerate underpayment recovery and denial appeals resolution - helping health systems recover more earned revenue as reimbursement complexity...
New capabilities accelerate underpayment recovery and denial appeals resolution - helping health systems recover more earned revenue as reimbursement complexity...
Leading esthetic monolithic zirconia now available in as little as 21 hours after scan submission IRVINE, CA / ACCESS Newswire...
Leading esthetic monolithic zirconia now available in as little as 21 hours after scan submission IRVINE, CA / ACCESS Newswire...
The company brings a fresh approach to revenue integrity, uniting revenue growth and risk mitigation within a single, disciplined framework....
The company brings a fresh approach to revenue integrity, uniting revenue growth and risk mitigation within a single, disciplined framework....
New research finds ACO digital infrastructure is shifting from retrospective reporting to risk-bearing operating command centers as payer APIs, APP...
New research finds ACO digital infrastructure is shifting from retrospective reporting to risk-bearing operating command centers as payer APIs, APP...
New acquisitions from Rain Foundation underlines Enlivex’s disciplined prediction markets treasury strategy Nes-Ziona, Israel, April 28, 2026 (GLOBE NEWSWIRE) --...
Livestream to Highlight TOMI’s Innovation Acceleration Business Model and Global Decontamination Growth StrategyFREDERICK, Md., April 28, 2026 (GLOBE NEWSWIRE) --...
New Taipei City, Taiwan, April 28, 2026 (GLOBE NEWSWIRE) -- Jyong Biotech Ltd. (Nasdaq: MENS) (the “Company” or “Jyong Biotech”),...
Analysis demonstrates statistically significant reduction in the severity of surgical wound infections, with potential to lower hospital resource utilization following...
Company’s prospective, multi-center 240-patient, pivotal randomized controlled trial (RCT) earns AUA “Practice-changing, Paradigm-shifting Clinical Trials in Urology (P2s)” designation at...
Company Planning Multi-Pronged Approach for QRX009 Including Several Investigator Led Clinical Studies in Key Indications. Company to Initiate Investigator Led...
SOLANA BEACH, Calif., April 28, 2026 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on...
ATLANTA, GA, April 28, 2026 (GLOBE NEWSWIRE) -- ExamWorks Group (“ExamWorks”), a leading global provider of medical claims management solutions,...
VivoSim’s NAMkind™ Intestinal Model combined with AI prediction tools yields high-accuracy resultsSAN DIEGO, April 28, 2026 (GLOBE NEWSWIRE) -- VivoSim Labs,...
The Company will Host a Conference Call and Webcast on May 12, 2026, at 8:30 AM ETCORAL GABLES, Fla., April...
Emergent’s Canton facility will manufacture drug substance and obtains exclusive distribution rights GAITHERSBURG, Md. and GENEVA, April 28, 2026 (GLOBE...
ROCKAWAY, N.J., April 28, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced...